Have a personal or library account? Click to login
Review: immune hemolytic anemia and/or positive direct antiglobulin tests caused by drugs Cover

Review: immune hemolytic anemia and/or positive direct antiglobulin tests caused by drugs

By: G. Garratty  
Paid access
|Nov 2020

References

  1. Garratty G. Drug-induced immune hemolytic anemia and/or positive direct antiglobulin tests. Immunohematology 1985;2:1–8.
  2. Garratty G. Current viewpoints on mechanisms causing drug-induced immune hemolytic anemia and/or positive direct antiglobulin tests. Immunohematology 1989;5:97–106.10.21307/immunohematology-2019-1075
  3. De Week AL. Low molecular weight antigens. In: Sela M, ed. The antigens. Vol. 2. New York: Academic Press, 1974:141–248.
  4. Landsteiner K. The specificity of serological reactions. Cambridge, MA: Harvard University Press, 1947.
  5. Kitagawa M, Yagi Y, Pressman D. The heterogeneity of combining sites of antibodies as determined by specific immunoadsorbents. II. Comparison of elution patterns obtained with anti-P-azobenzoate antibodies by different kinds of immunoadsorbent and eluting hapten. J Immunol 1965;95:455–65.10.4049/jimmunol.95.3.455
  6. Habibi B. Drug induced red blood cell autoantibodies co-developed with drug specific antibodies causing haemolytic anaemias. Br J Haematol 1985;61:139–43.10.1111/j.1365-2141.1985.tb04069.x
  7. Mueller-Eckhardt C, Salama A. Drug-induced immune cytopenias: a unifying pathogenic concept with special emphasis on the role of drug metabolites. Trans Med Rev 1990;4:69–77.10.1016/S0887-7963(90)70249-0
  8. Ackroyd JF. The immunological basis of purpura due to drug hypersensitivity. Proc R Soc Med 1962;55:30–6.10.1177/003591576205500109
  9. Miescher PA, Meischer A. Die sedormid-anaphylaxie. Schweiz Med Wochenschr 1952;82:1279–82.
  10. Miescher PA, Gorstein F. Mechanisms of immunogenic platelet damage. In: Johnson SA, Monto RW, Rebuck JW, Horn RC, eds. Blood platelets. London: Churchill, 1961:671.
  11. Miescher PA, Pepper JJ. Drug-induced immunologic blood dyscrasias: In: Miescher PA, Müller-Eberhard HJ, eds. Textbook of immunopathology. 2nd ed. Philadelphia: WB Saunders, 1976:421–32.
  12. Shulman NR. Immunoreactions involving platelets. I. A steric and kinetic model for formation of complex from a human antibody, quinidine as a haptene, and platelets; and for fixation of complement by the complex. J Exp Med 1958;107:665–90.10.1084/jem.107.5.665
  13. Shulman NR, Rail JE. Mechanism of blood ceil destruction in individuals sensitized to foreign antigens. Trans Assoc Am Physicians 1963;76:72–83.
  14. Shulman NR. A mechanism of cell destruction in individuals sensitized to foreign antigens and its implications in autoimmunity. Ann hit Med 1964;60:506–21.
  15. Worlledge SM. Immune drug-induced haemolytic anaemias. Sem Hematol 1969;6:181–200.
  16. Garratty G, Petz LD. Drug-induced immune hemolytic anemia. Am J Med 1975;58:398–407.10.1016/0002-9343(75)90606-3
  17. Petz LD, Garratty G. Acquired immune hemolytic anemias. New York: Churchill Livingstone, 1980.
  18. Ley AB, Harris JP, Brinkley M, et al. Circulating antibodies directed against penicillin. Science 1958;127:1118–9.10.1126/science.127.3306.1118
  19. Garratty G. Immune cytopenia associated with antibiotics. Trans Med Rev 1993;VII:255–67.10.1016/S0887-7963(93)70145-5
  20. Carstairs KC, Breckenridge A, Dollery CT, Worlledge SM. Incidence of a positive direct Coombs test in patients on α-methyldopa. Lancet 1966;2:133–5.10.1016/S0140-6736(66)92422-6
  21. Molthan L, Reidenberg MM, Eichman MF. Positive direct Coombs tests due to cephalothin. N Eng J Med 1967;277:123–5.10.1056/NEJM1967072027703036054993
  22. Gralnick HR, Wright LD Jr, McGinniss MH. Coombs’ positive reactions associated with sodium cephalothin therapy. JAMA 1967;199:135–6.10.1001/jama.1967.03120100087016
  23. Jamin D, Demers J, Shulman I, et al. An explanation for nonimmunologic adsorption of proteins onto red blood cells. Blood 1986;67:993–6.10.1182/blood.V67.4.993.993
  24. Jamin D, Shulman I, Lam HT, et al. Production of a positive direct antiglobulin test due to Suramin. Arch Pathol Lab Med 1988;112:898–900.
  25. Zeger G, Smith L, McQuiston D, Goldfinger D. Cisplatin-induced nonimmunologic adsorption of immunoglobulin by red cells. Transfusion 1988;28:493–5.10.1046/j.1537-2995.1988.28588337345.x
  26. Christie DJ, Mullen PC, Aster RH. Fab-mediated binding of drugdependent antibodies to platelets in quinidine- and quinine-induced thrombocytopenia. J Clin Invest 1985;75:310–4.10.1172/JCI111691
  27. Smith ME, Reid DM, Jones CE, et al. Binding of quinine- and quinidine-dependent drug antibodies to platelets is mediated by the Fab domain of the immunoglobulin G and is not Fc dependent. J Clin Invest 1987;79:912–7.10.1172/JCI112901
  28. Garratty G. Target antigens for red cell-bound autoantibodies. In: Nance SJ, ed. Clinical and serological aspects of immunohematology. Arlington, VA: American Association of Blood Banks, 1991:33–72.
  29. Christie DJ. Specificity of drug-induced immune cytopenias. Trans Med Rev 1993;VII:230–41.10.1016/S0887-7963(93)70143-1
  30. Kunicki TJ, Johnson MM, Aster RH. Absence of the plateletreceptor for drug-dependent antibodies in the Bernard-Soulier syndrome. J Clin Invest 1978;62:716–9.10.1172/JCI109181371820690191
  31. Chong BH, Berndt MC, Koutts J, Castaldi PA. Quinidine-induced thrombocytopenia and leukopenia: demonstration and characterization of distinct antiplatelet and anti-leukocyte antibodies. Blood 1983;62:1218–23.10.1182/blood.V62.6.1218.1218
  32. van Leeuwen EF, Engelftiet CP, von dem Borne AEG Kr. Studies on quinine- and quinidine-dependent antibodies against platelets and their reaction with platelets in the Bernard-Soulier syndrome. Br J Haematol 1982;51:551–60.10.1111/j.1365-2141.1982.tb02818.x7049220
  33. Visentin GP, Newman PJ, Aster RH. Characteristics of quinine- and quinidine-induced antibodies specific for platelet glycoproteins IIb and IIla. Blood 1991;77:2668–76.10.1182/blood.V77.12.2668.2668
  34. Christie DJ, Aster RH. Drug-antibody-platelet interaction in quinine- and quinidine-induced thrombocytopenia. J Clin Invest 1982;70:989–98.10.1172/JCI1107103703116215430
  35. Martinez J, Letona J, Barbolla L, et al. Immune haemolytic anaemia and renal failure induced by streptomycin. Br J Haematol 1977;35:561–71.10.1111/j.1365-2141.1977.tb00621.x405985
  36. Duran-Suarez JR, Martin-Vega C, Argelagues E, et al. Red cell I antigen as immune complex receptor in drug-induced hemolytic anemias. Vox Sang 1981;41:313–5.10.1111/j.1423-0410.1981.tb01055.x7324446
  37. Habibi B, Bretagne Y. Blood group antigens may be the receptors for specific drug-antibody complexes reacting with red blood cells. C R Acad Sci (D) (Paris) 1983;296:693–6.
  38. Sosler SD, Behzad O, Garratty G, et al. Acute hemolytic anemia associated with a chlorpropamide-induced apparent auto anti-Jka. Transfusion 1984;24:206–9.10.1046/j.1537-2995.1984.24384225022.x6427987
  39. Habibi B. Basty R, Chodez S, Prunat A. Thiopental-related immune hemolytic anemia and renal failure. N Eng J Med 1985;312:353–5.10.1056/NEJM1985020731206063969087
  40. Salama A, Mueller-Eckhardt C. On the mechanisms of sensitization and attachment of antibodies to RBC in drug-induced immune hemolytic anemia. Blood 1987;69:1006–10.10.1182/blood.V69.4.1006.1006
  41. Sandvei P, Nordhagen R, Michaelsen TE, Wolthius K. Fluorouracil (5-FU) induced acute immune haemolytic anaemia. Br J Haematol 1987;65:357–9.10.1111/j.1365-2141.1987.tb06868.x3567089
  42. Pereira A, Sanz C, Cervantes F, Castillo R. Immune hemolytic anemia and renal failure associated with rifampicin-dependent antibodies with anti-I specificity. Ann Hematol 1991;63:56–8.10.1007/BF017149641878425
  43. Weitekamp LA, Johnson ST, Fueger JT, Clark JR, Aster RH. A fatal case of tolmetin-induced hemolytic anemia with relative e specificity (abstract). Transfusion 1991;31:52S.
  44. Jackson V, Storry J, Futral D. A fatal case of tolmetin-induced immune hemolysis, disseminated intravascular coagulation, and acute renal failure. Immunohematology 1992;8:79.10.21307/immunohematology-2019-990
  45. DeCoteau J, Reis MD, Pinkerton PH, Ward J, Coovadia AS. Positive antiglobulin test in association with sulindac: involvement of the Rh factor. Vox Sang 1993;64:179–83.10.1111/j.1423-0410.1993.tb05159.x8484252
  46. Beck ML. A fatty-acid dependent antibody with Rh specificity (abstract). In: Book of abstracts from the ISBT/AABB Joint Congress. Arlington, VA: American Association of Blood Banks, 1972:6.
  47. Dube VE, Zoes C, Adesman P. Caprylate-dependent auto-anti-e. Vox Sang 1977;33:359–63.10.1111/j.1423-0410.1977.tb02257.x412322
  48. Reviron M, Janvier D, Reviron J, Lagabrielle JF. An anti-I cold autoagglutinin enhanced in the presence of sodium azide. Vox Sang 1984;46:211–6.10.1111/j.1423-0410.1984.tb00077.x6369782
  49. Halima D, Garratty G, Bueno R. An apparent anti-Jka reacting only in the presence of methyl esters of hydroxybenzoic acid. Transfusion 1982;22:521–4.10.1046/j.1537-2995.1982.22683068617.x7147330
  50. Judd WJ, Steiner EA, Cochran RK. Paraben-associated autoanti-Jka antibodies. Transfusion 1982;22:31–5.10.1046/j.1537-2995.1982.22182154211.x7064203
  51. Muirhead EE, Groves M, Guy R, et al. Acquired hemolytic anemia, exposure to insecticides and positive Coombs test dependent on insecticide preparations. Vox Sang 1959;4:277–92.10.1111/j.1423-0410.1959.tb03629.x14425063
  52. Hart MN, Mesara BW. Phenacetin antibody cross-reactive with autoimmune erythrocyte antibody. Am J Clin Pathol 1969;52:695–701.10.1093/ajcp/52.6.6955353837
  53. Shulman LA, Arndt PA, McGehee W, Garratty G. Cefotaxime-induced immune hemolytic anemia due to antibodies reacting in vitro by more than one mechanism. Transfusion 1990;30:263–6.10.1046/j.1537-2995.1990.30390194351.x2316002
  54. Garratty G, Houston M, Petz LD, Webb M. Acute immune intravascular hemolysis due to hydrochlorothiazide. Am J Clin Pathol 1981;76:73–8.10.1093/ajcp/76.1.737258154
  55. Garratty G, Nance S, Lloyd M, Domen R. Fatal immune hemolytic anemia due to cefotetan. Transfusion 1992;32:269–71.10.1046/j.1537-2995.1992.32392213813.x1557811
  56. Florendo NT, MacFarland D, Painter M, Muirhead EE. Streptomycin-specific antibody coincident with a developing warm autoantibody. Transfusion 1980;20:662–8.10.1046/j.1537-2995.1980.20681057155.x7434449
  57. Habibi B, Lopez M, Serdaru M, et al. Immune hemolytic anemia and renal failure due to teniposide. N Eng J Med 1982;306:1091–3.10.1056/NEJM198205063061806
  58. Bird GWG, Wingham J, Babb RG, et al. Azapropazone-associated antibodies. Vox Sang 1984;46:336–7.10.1111/j.1423-0410.1984.tb00095.x
  59. Salama A, Mueller-Eckhardt C. Two types of nomifensine-induced immune haemolytic anaemias: drug-dependent sensitization and/or autoimmunization. Br J Haematol 1986;64:613–20.10.1111/j.1365-2141.1986.tb02217.x
  60. Salama A, Mueller-Eckhardt C. Cianidanol and its metabolites bind tightly to red cells and are responsible for the production of auto- and/or drug-dependent antibodies against these cells. Br J Haematol 1987;66:263–6.10.1111/j.1365-2141.1987.tb01309.x
  61. Salama A, Göttsche B, Mueller-Eckhardt C. Autoantibodies with drug- or metabolite-dependent antibodies in patients with diclofenac-induced immune haemolysis. Br J Haematol 1990;77:546–9.10.1111/j.1365-2141.1991.tb08624.x
  62. Squires JE, Mintz PD, Clark S. Tolmetin-induced hemolysis. Transfusion 1985;25:410–3.10.1046/j.1537-2995.1985.25586020111.x
  63. van Dijk BA, Rico PB, Hoitsma A, Kunst VAJM. Immune hemolytic anemia associated with tolmetin and suprofen. Transfusion 1989;29:638–41.10.1046/j.1537-2995.1989.29789369685.x
  64. Schulenburg BJ, Beck ML, Pierce SR, et al. Immune hemolysis associated with Zomax™ (abstract). Transfusion 1983;23:409.
  65. Garratty G. Severe immune haemolytic anaemia associated with newer cephalosporins. Lancet 1991;338:119–20.10.1016/0140-6736(91)90111-2
  66. Salama A, Northoff H, Burkhardt H, Mueller-Eckhardt C. Carbimazole-induced immune haemolytic anaemia: role of drug-red blood cell complexes for immunization. Br J Haematol 1988;68:479–82.10.1111/j.1365-2141.1988.tb04240.x3377989
  67. Weitekamp LA, Johnson ST, Fueger JT, et al. Cefotetan-dependent immune hemolytic anemia due to a single antibody reacting with both drug coated and untreated red cells in the presence of drug (abstract). In: Book of abstracts from the ISBT/AABB Joint Congress. Arlington, VA: American Association of Blood Banks, 1990:33.
  68. Wojcicki RE, Larson CJ, Pope ME, Sullivan CM. Acute hemolytic anemia during cefotetan therapy (abstract). In: Book of abstracts from the ISBT/AABB Joint Congress. Arlington, VA: American Association of Blood Banks, 1990:33.
  69. Chambers LA, Donovan LM, Kruskall MS. Ceftazidime-induced hemolysis in a patient with drug-dependent antibodies reactive by immune complex and drug adsorption mechanisms. Am J Clin Pathol 1991;95:393–6.10.1093/ajcp/95.3.3931996549
  70. Gallagher MT, Schergen AK, Sokol-Anderson ML, et al. Severe immune mediated hemolytic anemia secondary to treatment with cefotetan. Transfusion 1992;32:266–8.10.1046/j.1537-2995.1992.32392213812.x
  71. Ehmann WC. Cephalosporin-induced hemolysis: a case report and review of the literature. Am J Hematol 1992;40:121–5.10.1002/ajh.2830400209
  72. Munizza M, Kavitsky D, Schainker BA, Poyser A, Peek C, Nance S. Hemolytic anemia associated with injection of fluorescein. Transfusion 1993;33:689–92.10.1046/j.1537-2995.1993.33893342754.x
  73. Salama A, Mueller-Eckhardt C. Immune-mediated blood cell dyscrasias related to drug. Sem Hematol 1992;29:54–63.
  74. Kirtland HH, Mohler DN, Horwitz DA. Methyldopa inhibition of suppressor-lymphocyte function. N Eng J Med 1980;302:825–32.10.1056/NEJM198004103021502
  75. Garratty G. Drug-induced immune hemolytic anemia. In: Garratty G, ed. Immunobiology of transfusion medicine. New York: Dekker, 1993:523–51.
  76. Shulman NR, Reid DM. Mechanisms of drug-induced immunologically mediated cytopenias. Trans Med Rev 1993;7:215–29.10.1016/S0887-7963(93)70142-X
  77. White JM, Brown DL, Hepner GW, Worlledge SM. Penicillin-induced haemolytic anaemia. Br Med J 1968;3:26–9.10.1136/bmj.3.5609.2619894885661907
  78. Garratty G. The clinical significance (and insignificance) of red-cell-bound IgG and complement. In: Wallace ME, Levitt JS, eds. Current applications and interpretation of the direct antiglobulin test. Arlington, VA: American Association of Blood Banks, 1988:1–24.
  79. Budavari S, ed. The Merck index: an encyclopedia of chemicals, drugs, and biologicals. 11th ed. Rahway, NJ: Merck & Co., 1989.
  80. Curtis BR, McFarland JG, Aster RH. Enhanced detection of antibodies (DDAb) responsible for drug-induced thrombocytopenia (DITP) (abstract). Transfusion 1993;33:77S.
  81. Salama A, Mueller-Eckhardt C, Kissel K, Pralle H, Seeger W. Ex vivo antigen preparation for the serological detection of drugdependent antibodies in immune haemolytic anaemias. Br J Haematol 1984;58:525–31.10.1111/j.1365-2141.1984.tb04000.x6208933
  82. Garratty G, Petz LD. The investigation of drug-induced problems in the blood bank. 1st ed. Washington, DC: American Association of Blood Banks, 1974:1–29.
  83. Branch DR, Sy Siok Hian AL, Petz LD. Mechanism of nonimmunologic adsorption of proteins using cephalothin-coated red cells (abstract). Transfusion 1984;24:415.
DOI: https://doi.org/10.21307/immunohematology-2019-817 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 41 - 50
Published on: Nov 22, 2020
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2020 G. Garratty, published by American National Red Cross
This work is licensed under the Creative Commons License.